Drug · DIN 02478579
BIKTARVY
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 8, 2018; first marketed August 8, 2018.
- Drug Identification Number (DIN)
- 02478579
- Company (DIN owner)
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Emtricitabine, tenofovir alafenamide and bictegravir J05AR20
- Class
- Human
- Record last updated
- July 25, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BICTEGRAVIR (BICTEGRAVIR SODIUM) | 50 MG | |
| EMTRICITABINE | 200 MG | |
| TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 10, 2018: NOC 21065New Drug Submission (NDS)